Neffy Spray
Product Images NDC 82580-020

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Neffy (NDC 82580-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ars Pharmaceuticals Operations, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Neffy 01)

An instructional illustration showing the administration of neffy nasal spray. It depicts a person inserting the spray device into one nostril for the first dose, followed by the second dose delivered into the same nostril, demonstrating proper usage technique.*

FDA Label Image

Chemical Structure (Neffy 02)

Chemical structure diagram of epinephrine showing its molecular framework with hydroxyl groups, an amine side chain, and aromatic ring features.*

FDA Label Image

Figure 2 (Neffy 03)

A line graph showing median heart rate (HR) change from baseline over 60 minutes for three epinephrine products: neffy 2 mg nasal spray, epinephrine 0.3 mg via needle-syringe, and epinephrine 0.3 mg via auto-injector. The y-axis represents median HR change in beats per minute, and the x-axis represents time in minutes.*

FDA Label Image

Figure 2 (Neffy 04)

Line graph depicting the median systolic blood pressure (SBP) change from baseline over time in minutes. It compares Neffy 2 mg nasal spray with epinephrine 0.3 mg administered via needle-syringe and auto-injector methods, showing variations in blood pressure response across a 60-minute period.*

FDA Label Image

Figure 3 (Neffy 05)

A line graph showing median pulse rate (PR) change in beats per minute (bpm) over time (minutes) for three formulations of epinephrine nasal spray: neffy 2 mg twice R/L without NAC, neffy 2 mg twice R/L with NAC, and epinephrine 0.3 mg twice R/L with NAC. The graph compares PR changes from 0 to 60 minutes post-administration.*

FDA Label Image

Figure 3 (Neffy 06)

A line graph showing median systolic blood pressure (SBP) change in mmHg over time in minutes for three different treatments: neffy 2 mg twice R/L (without NAC), neffy 2 mg twice R/R (with NAC), and Epinephrine 0.3 mg twice R/L (with NAC). The graph compares the blood pressure response over a 60-minute period.*

FDA Label Image

Figure 4 (Neffy 07)

A line graph comparing epinephrine plasma concentration (pg/mL) over time (minutes) for three formulations: neffy 2 mg nasal spray, epinephrine 0.3 mg needle-syringe injection, and epinephrine 0.3 mg auto-injector. The graph shows concentration trends from 0 to 60 minutes with error bars for variability.*

FDA Label Image

Figure 5a (Neffy 08)

A line graph comparing epinephrine plasma concentration (pg/mL) over time (minutes) for neffy 2 mg nasal spray with and without NAC, and epinephrine via needle-syringe at 0.3 mg and 0.5 mg doses. The graph illustrates concentration changes up to 60 minutes post-administration.*

FDA Label Image

Figure 5b (Neffy 09)

A line graph showing the geometric mean concentration (pg/mL) over time (minutes) for three nasal spray formulations: neffy 2 mg administered twice via R/L without NAC, neffy 2 mg administered twice via R/L with NAC, and epinephrine 0.3 mg administered twice via R/L with NAC, illustrating concentration changes within a 60-minute period.*

FDA Label Image

Principal Display Panel (2 mg Spray Device Blister Pack Carton)

Neffy (epinephrine nasal spray) 2 mg carton packaging with instructions for single-dose nasal use. The label includes directions on proper spray technique, dosage information, storage conditions, a barcode, website, and contact number for ARS Pharmaceuticals Operations, Inc. It states the carton contains two single-dose nasal spray devices.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.